Qingyi R. Zhu

155 Han Zhong Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort.

Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort.

Journal: Minerva urology and nephrology

Published: July 13, 2026

EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer.

EP300-Mediated MTF1-K218 Lactylation Buffers AR-Driven Copper Overload to Suppress Cuproptosis in Castration-Resistant Prostate Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 07, 2026

Fueling death: Glucose metabolic reprogramming regulates ferroptosis and cuproptosis in cancer.

Fueling death: Glucose metabolic reprogramming regulates ferroptosis and cuproptosis in cancer.

Journal: Biochemical and biophysical research communications

Published: April 02, 2026

Atherogenic index of plasma and risk of hypertensive disorders of pregnancy in women with gestational diabetes mellitus: a two-center cohort study.

Atherogenic index of plasma and risk of hypertensive disorders of pregnancy in women with gestational diabetes mellitus: a two-center cohort study.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: March 10, 2026

Single-cell and machine learning integration reveals OS-driven CCND1 promotes an aggressive phenotype in papillary thyroid carcinoma.

Single-cell and machine learning integration reveals OS-driven CCND1 promotes an aggressive phenotype in papillary thyroid carcinoma.

Journal: Frontiers in immunology

Published: October 10, 2025

Decoding lactylation landscapes: Metabolic-epigenetic crosstalk through histone/non-histone modifications as drivers of disease progression and treatment resistance.

Decoding lactylation landscapes: Metabolic-epigenetic crosstalk through histone/non-histone modifications as drivers of disease progression and treatment resistance.

Journal: Biochemical and biophysical research communications

Published: August 15, 2025

Chemotherapy sequential disitamab vedotin in combination with tislelizumab as systemic therapy of upper tract urothelial carcinoma with cutaneous metastasis: A case report and literature review.

Chemotherapy sequential disitamab vedotin in combination with tislelizumab as systemic therapy of upper tract urothelial carcinoma with cutaneous metastasis: A case report and literature review.

Journal: Medicine

Published: July 21, 2025

Current Applications and Future Prospects of Laparoendoscopic Single-Site Surgery in Urology

Current Applications and Future Prospects of Laparoendoscopic Single-Site Surgery in Urology

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

Published: July 18, 2025

N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis.

N6-methyladenosine-modified circLPAR3 drives docetaxel resistance in prostate cancer by suppressing ferroptosis through the PCBP2/CHAC1 axis.

Journal: Genes & diseases

Published: April 28, 2025

Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.

Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer.

Journal: BMC cancer

Published: April 22, 2025

Vaginal microbiota in late pregnancy associates with the outcomes of planned induced labor: a multicenter prospective cohort study.

Vaginal microbiota in late pregnancy associates with the outcomes of planned induced labor: a multicenter prospective cohort study.

Journal: American journal of obstetrics and gynecology

Published: March 28, 2025

Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach.

Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach.

Journal: Biomedicines

Published: February 27, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026